Search For "pharma"
Piramal Critical Care and Blue-Zone Technologies collaborate to capture, c
Updated : 1 month, 1 week ago IST
Mumbai (Maharashtra) [India], February 6: Piramal Critical Care, Inc. (PCC), an overseas subsidiary of Piramal Pharma Limited, and Blue-Zone Technologies Ltd. (Blue-Zone) announced an agreement to collaborate on full lifecycle technology to capture and recycle waste anaesthetic gases.
Read More
Academically Launches Jobslly, India's First Dedicated Career Platform for
Updated : 1 month, 1 week ago IST
Dehradun (Uttarakhand) [India], February 5: Academically Global announced the launch of Jobslly, a first-of-its-kind healthcare-focused career platform created to support doctors, pharmacists, dentists, physiotherapists, and allied healthcare professionals in getting high-paying job opportun
Read More
India aids US to crackdown on illegal drug trafficking
Updated : 1 month, 1 week ago IST
The US Drug Enforcement Administration, with the cooperation of the US Attorney's Office for the Eastern District of New York, announced the seizure of more than 200 website domains tied to an India-based transnational criminal organization (TCO) working within the United States and alleg
Read More
Lupin Receives Highest ESG Rating from CDP for Climate Change and Water Se
Updated : 1 month, 1 week ago IST
Mumbai (Maharashtra) [India], February 4: Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received the highest 'A' leadership rating from Climate Disclosure Project (CDP) for its exceptional accomplishmen
Read More
"Crucial moment for pharma industry": CSIR-CDRI Director Radha Rangarajan
Updated : 1 month, 1 week ago IST
CSIR-CDRI Director Radha Rangarajan, on Tuesday, stated the 'Uttar Pradesh Pharma Conclave 1.0' is one of the most crucial moments of the pharmaceutical industry and plays a major role in the industry's growth and expansion in the State.
Read More
"Grateful to PM Modi, Donald Trump for reducing tariffs on Indian goods:"
Updated : 1 month, 1 week ago IST
Uttar Pradesh Chief Minister on Tuesday thanked PM Narendra Modi and US President Donald Trump for reducing tariffs on Indian goods and recognising India as a reliable partner.
Read More
Union Budget 2026 takes major steps to overcome shortcomings in Pharma sec
Updated : 1 month, 1 week ago IST
Speaking on the Union Budget 2026-27, Indian Council of Medical Research (ICMR) Director General Rajiv Bahl noted that the government has initiated a significant push to transform the country's pharmaceutical landscape by addressing regulatory gaps and enhancing research infrastructure. S
Read More
Budget reinforces long-term biopharma growth despite no new tax incentives
Updated : 1 month, 1 week ago IST
The Union Budget 2026 has signalled a sustained policy push for India's pharmaceutical and life sciences sector, with a strong emphasis on biopharma innovation, research infrastructure and affordability, even as direct tax incentives remain unchanged, noted EY's Budget sectoral alert.
Read More
"Budget has special focus on mental health and combating mental illness...
Updated : 1 month, 1 week ago IST
Union Minister JP Nadda on Sunday called the Union Budget 2026-27 "visionary," underlining that it has a special focus on mental health and combating mental illness.
Read More
"Futuristic": Union Minister Jitendra Singh hails Budget 2026-27
Updated : 1 month, 1 week ago IST
Union Minister Dr Jitendra Singh on Sunday described the Union Budget 2026-27 as a "very futuristic" blueprint, charting a roadmap for the next 25 years, including India's 2047 vision of 'Viksit Bharat'.
Read More
"Budget has lot for health sector, India moving with mantra of self-relian
Updated : 1 month, 1 week ago IST
Anupriya Pate welcomed the fiscal plan, noting that the country is advancing its independence in the manufacturing and research sectors.
Read More
India has potential to be a leader in bio-medicine: ICMR DG Rajiv Bahl hai
Updated : 1 month, 1 week ago IST
Apart from the increased allocation, the central drug regulator has been strenghtened, a plan for building over 1,000 medical trial sites has been announced, and cancer medicines have been exempted from custom duties.
Read More